Roche Holding AG Inventory Turnover Ratio 2006-2019 | RHHBY

Current and historical inventory turnover ratio for Roche Holding AG (RHHBY) from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Roche Holding AG inventory turnover ratio for the three months ending December 31, 2019 was .
Roche Holding AG Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $296.540B $61.869B
Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $386.574B 16.52
Merck (MRK) United States $205.840B 14.91
Pfizer (PFE) United States $200.030B 12.42
Novartis AG (NVS) Switzerland $195.078B 15.23
Novo Nordisk (NVO) Denmark $151.508B 25.23
Eli Lilly (LLY) United States $144.147B 23.33
AstraZeneca (AZN) United Kingdom $141.375B 29.12
Bristol-Myers Squibb (BMY) United States $137.775B 11.51
AbbVie (ABBV) United States $137.396B 10.09
Sanofi (SNY) $125.082B 14.48
GlaxoSmithKline (GSK) United Kingdom $104.480B 12.47
Bayer (BAYRY) Germany $66.771B 9.52
H Lundbeck (HLUYY) Denmark $8.078B 14.04
Innoviva (INVA) United States $1.403B 8.10